Philips North America vs UMEDICA: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for UMEDICA.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

UMEDICA: 0 warning letters, 0 recalls, 2 approval records, 0 Form 483s.

Side by side

Philips North America — Warning letters0

UMEDICA — Warning letters0

Philips North America — Recalls355

UMEDICA — Recalls0

Philips North America — Approval records0

UMEDICA — Approval records2

Philips North America — Form 483s0

UMEDICA — Form 483s0

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

UMEDICA

Most recent FDA action: August 5, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs UMEDICA: FDA Enforcement Comparison." Argus HQ, accessed August 13, 2026. https://argushq.ai/compare/philips-north-america-vs-umedica

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗